Primagen Holding

Primagen Holding B.V. devel­ops mol­e­c­u­lar tests and prod­ucts for the detec­tion of virus­es and cer­tain forms of can­cer.

Portfolio: MedSciences Capital B.V.

Current prod­uct devel­op­ment stage: tech­nol­o­gy out­li­censed to glob­al­ly oper­at­ing man­u­fac­tur­ers of diag­nos­tics.